COMPUMEDICS LIMITED - News & Media

1.79%

28.5¢

Market Cap $56.93M

Healthcare Medical Devices

Compumedics is at an inflection point—scaling FDA-cleared platforms (Somfit®),... Compumedics is at an inflection point—scaling FDA-cleared platforms (Somfit®), commercializing world-class neuroimaging (OrionMEG®), and building recurring SaaS revenues. Combined with strong FY25 execution and a Board focused on capital markets, CMP is poised to unlock both operational growth and a capital market re-rating.More

Corporate Spotlight

Compumedics is at an inflection point—scaling FDA-cleared platforms (Somfit®), commercializing world-class neuroimaging (OrionMEG®), and building recurring SaaS revenues. Combined with strong FY25 execution and a Board focused on capital markets, CMP is poised to unlock both operational growth and a
View the full Corporate Spotlight

COMPUMEDICS EYES $70M FY26 TARGET AHEAD OF US PIVO

Articles & Videos

Compumedics eyes $70M FY26 target ahead of US pivot – and a potential $1B US IPO

Welcome to the latest HotCopper Capital Compass, where we’ve this week spoken to Compumedics Ltd (ASX:CMP) founder and CEO David Burton to discuss the company’s history, its work developing technologies in the sleep neurology and brain imaging space, and what lies ...

11 Mar 2026 15:00 (AEDT)

Compumedics delivers record H1 update as SaaS and US launch drive growth

Welcome to the latest HotCopper Watchlist interview, where we’ve spoken to Compumedics Ltd (ASX:CMP) CFO David Lawson to discuss the company’s H1FY26 results, including revenue growth, and ongoing SaaS strategy.Listen to the HotCopper podcast for in-depth discussio...

04 Mar 2026 09:52 (AEDT)

Profit-making Compumedics clocks record sales in H1FY26; SaaS revenue up +56%

Compumedics (ASX:CMP) has officially clocked a A$0.3M profit in the first half of FY26, officially bringing the company into profitability after a -$1.1M loss pcp.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotif...

25 Feb 2026 13:03 (AEDT)

Compumedics snags sixth order for Orion LifeSpan at $4.2M heading to Shandong

Compumedics has inked a fresh $4.2M order to kick off CY26 with a sixth unit of its Orion LifeSpan MEG tech heading to Shandong University.

29 Jan 2026 10:52 (AEDT)

Healthcare disruptor Compumedics clocks record sales in 1H FY26 at $33M; revenue up +32%

Compumedics has posted its highest-ever sales figure, netting $33M in the first half of FY26, also seeing shipped revenues climb over +30%.

22 Jan 2026 10:29 (AEDT)

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big breakthrough in imaging tech.

16 Dec 2025 13:39 (AEDT)

Compumedics locks in $5M sales order for its MEG brain imaging tech

Compumedics has inked the fifth order with a customer worth $5 million for its magnetoencephalography-based (MEG) brain scanner tech.

10 Nov 2025 11:26 (AEDT)

Compumedics wraps up $2.15M raise to accelerate Somfit D commercialisation

Compumedics has completed a $2.15 million placement to accelerate the commercialisation of its Somfit D sleep diagnostic device.

15 Oct 2025 09:12 (AEDT)

Compumedics sees record sales orders, continued momentum across core and emerging platforms

Compumedics (ASX:CMP) has seen record sales orders and continued momentum across its core and emerging platforms.

10 Oct 2025 09:47 (AEDT)

Capital Compass: Compumedics' CEO David Burton on why 2026 is looking like a transformational year – thanks to AI

Compumedics (ASX:CPM), a world leader in sleep and neuro diagnostics, is growing as a company, which isn’t surprising when considering the growing prevalence of modern health conditions affecting neuro behaviours like sleep. For more than three decades, the company has been drivin...

01 Oct 2025 13:48 (AEST)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 28.5¢		Change 0.005(1.79%)		Mkt cap ! $56.93M

Open	High	Low	Volume
28.5¢	29.5¢	28.5¢	13.72K

Buyers (Bids)

Vol.	Price($)
9000	29.0¢

Sellers (Offers)

Price($)	Vol.
29.5¢	48780

Last trade - 13.52pm 20/04/2026 (20 minute delay)

CMP (ASX) Chart